Micafungin is a semi-synthetic lipopeptide antifungal medication used to treat various fungal infections, including aspergillosis, candidiasis, and Pneumocystis jirovecii pneumonia. With the increasing demand for antifungal medications worldwide, micafungin has become a popular choice among healthcare professionals and patients alike. This article aims to provide a comprehensive guide to the global buyers list of micafungin, helping pharmaceutical suppliers expand their business and tap into new markets. Market Trends: The global micafungin market size was valued at USD 1.02 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.3% from 2021 to 2028. The increasing prevalence of fungal infections, rising healthcare expenditures, and growing…